Ziphius Vaccines is a self-amplifying RNA company developing vaccines for infectious diseases and gene supplementation therapies, aiming to create a new generation of medical tools.
Our Pipeline
Z007
Chlamydia trachomatis
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Z007
Chlamydia trachomatis
Z004
Cystic Fibrosis
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Z004
Cystic Fibrosis
Z008
Oncology
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Z008
Oncology
Z006
Undisclosed
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Z006
Undisclosed
Partnering
Product Partnering
Partnerships with Ziphius can be made to develop LNP-encapsulated saRNA based vaccines on an out-licensing or risk-sharing basis.
Technology Partnering
Ziphius seeks collaborations to explore its various platform technologies in various disease areas.